HK1220279A1 - 預測對精神疾病治療的應答的方法和系統 - Google Patents

預測對精神疾病治療的應答的方法和系統

Info

Publication number
HK1220279A1
HK1220279A1 HK16108293.9A HK16108293A HK1220279A1 HK 1220279 A1 HK1220279 A1 HK 1220279A1 HK 16108293 A HK16108293 A HK 16108293A HK 1220279 A1 HK1220279 A1 HK 1220279A1
Authority
HK
Hong Kong
Prior art keywords
treatments
mental disorders
predict response
predict
response
Prior art date
Application number
HK16108293.9A
Other languages
English (en)
Inventor
Guangdan Zhu
Cindy Wang
Tanya Moreno
Andrew Hellman
Alok Tomar
Svetlana Ivanova Gramatikova
Aditi Chawla
Russell Kuo-Fu Chan
Andria Del Tredici
Adrian Vilalta
K David Becker
Michael Nova
Original Assignee
Pathway Genomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathway Genomics Corp filed Critical Pathway Genomics Corp
Publication of HK1220279A1 publication Critical patent/HK1220279A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Theoretical Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Computing Systems (AREA)
  • Databases & Information Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK16108293.9A 2013-03-15 2016-07-14 預測對精神疾病治療的應答的方法和系統 HK1220279A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361800278P 2013-03-15 2013-03-15
US201361800206P 2013-03-15 2013-03-15
US13/917,573 US20140274764A1 (en) 2013-03-15 2013-06-13 Method and system to predict response to treatments for mental disorders
PCT/US2014/024314 WO2014150817A2 (en) 2013-03-15 2014-03-12 Method and system to predict response to treatments for mental disorders

Publications (1)

Publication Number Publication Date
HK1220279A1 true HK1220279A1 (zh) 2017-04-28

Family

ID=51529822

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108293.9A HK1220279A1 (zh) 2013-03-15 2016-07-14 預測對精神疾病治療的應答的方法和系統

Country Status (5)

Country Link
US (3) US20140274764A1 (zh)
EP (1) EP2973364A4 (zh)
BR (1) BR112015022472A2 (zh)
HK (1) HK1220279A1 (zh)
WO (1) WO2014150817A2 (zh)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL199534A (en) 2007-01-05 2013-01-31 Univ Zuerich An isolated human antibody capable of detecting a neoepitope in a disease-related protein, a polynucleotide encoding an antibody, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, a preparation containing the antibody and related methods and uses.
WO2015006475A1 (en) * 2013-07-12 2015-01-15 Biogen Idec International Neuroscience Gmbh Genetic and image biomarkers associated with decline in cognitive measures and brain glucose metabolism in populations with alzheimer's disease or those susceptible to developing alzheimer's disease
US11037684B2 (en) * 2014-11-14 2021-06-15 International Business Machines Corporation Generating drug repositioning hypotheses based on integrating multiple aspects of drug similarity and disease similarity
MA41115A (fr) 2014-12-02 2017-10-10 Biogen Int Neuroscience Gmbh Procédé de traitement de la maladie d'alzheimer
WO2016123543A1 (en) * 2015-01-30 2016-08-04 Takeda Pharmaceuticals U.S.A., Inc. Method for treating schizophrenia comprising administering lurasidone
US9932638B2 (en) * 2015-06-29 2018-04-03 Millennium Health, LLC Single nucleotide polymorphism in HLA-B*15:02 and use thereof
WO2017161289A1 (en) * 2016-03-18 2017-09-21 Takeda Pharmaceutical Company Limited Method for identifying clinical trial responders from a placebo group in major depression
EP3433380B1 (en) * 2016-03-21 2022-06-08 Indiana University Research & Technology Corporation Drugs, pharmacogenomics and biomarkers for active longevity
CN115813888A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
AU2018204841B2 (en) * 2017-07-05 2023-08-10 Medtronic Ardian Luxembourg S.A.R.L. Methods for treating post-traumatic stress disorder in patients via renal neuromodulation
SG11202001281WA (en) 2017-08-22 2020-03-30 Biogen Ma Inc Pharmaceutical compositions containing anti-beta amyloid antibodies
WO2019046303A1 (en) * 2017-08-28 2019-03-07 The Trustees Of Columbia University In The City Of New York METHOD FOR PREDICTING PATIENT RESPONSE TO SLC MODULATOR PROCESSING
EP3707275A4 (en) * 2017-11-07 2021-11-10 Medreleaf Corp. DOSAGE AND STRATEGY RECOMMENDATIONS FOR THE TREATMENT OF MEDICAL CONDITIONS USING CANNABIS
CN108070659B (zh) * 2017-12-27 2020-05-05 中国医学科学院肿瘤医院 Snp标志物在预测tam辅助内分泌治疗乳腺癌患者疗效中的应用
CN108319807B (zh) * 2018-01-05 2019-12-17 东北大学 一种掺杂式能源材料的高通量计算筛选方法
KR102047479B1 (ko) * 2018-01-24 2019-11-21 전남대학교산학협력단 노년기우울증 검출방법 및 진단키트
CN108179192A (zh) * 2018-02-06 2018-06-19 徐州医科大学 一种基因多态性变异位点早期诊断子宫内膜癌的试剂盒
US20190264285A1 (en) * 2018-02-23 2019-08-29 Northwestern University Polymorphisms for predicting treatment response to antipsychotic drugs and idenfying new drug targets
CN108546754B (zh) * 2018-05-08 2021-12-03 上海交通大学医学院附属上海儿童医学中心 一种基于多色探针熔解曲线分析的喹硫平、阿立哌唑药物基因组学检测方法
MX2020014286A (es) 2018-06-20 2021-03-25 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
CN109112188A (zh) * 2018-06-26 2019-01-01 苏州道尔盾基因科技有限公司 一种hla-b*1502基因的检测方法及检测试剂盒
WO2020092240A1 (en) * 2018-10-29 2020-05-07 Northwestern University Big data-driven personalized management of chronic pain
KR102219694B1 (ko) * 2018-11-22 2021-02-24 인제대학교 산학협력단 항정신용제 약물 반응 및 부작용과 관련된 cyp3a5, ugt2b15, comt, htr2a 및 bndf의 대립유전자에 대한 검출 방법
CN109439742A (zh) * 2018-12-07 2019-03-08 北京华夏时代基因科技发展有限公司 用于质子泵抑制药代谢和耐药基因snp检测的核苷酸组合
US20220057416A1 (en) * 2018-12-21 2022-02-24 Thsee, Llc Method for optimization of cannabis dosage and mixture of active cannabinoids
AU2019414963A1 (en) * 2018-12-28 2021-08-19 Xing-Liang Liu Methods and systems for providing a personalized cannabinoid treatment regimen
US20200234810A1 (en) 2019-01-23 2020-07-23 The Regent Of The University Of Michigan Pharmacogenomic Decision Support for Modulators of the NMDA, Glycine, and AMPA Receptors
CN109825574A (zh) * 2019-03-20 2019-05-31 宁波海尔施基因科技有限公司 一种用于抗癫痫药物用药指导的多重基因检测试剂盒及其使用方法
US20220202756A1 (en) * 2019-04-09 2022-06-30 Vistagen Therapeutics, Inc. Genetic variants associated with response to treatment of neurological disorders
US20220290237A1 (en) * 2019-04-24 2022-09-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for predicting the response of antipsychotic drugs
CN110079596A (zh) * 2019-04-26 2019-08-02 宁波海尔施基因科技有限公司 一种用于抗躁狂药物用药指导的多重基因检测试剂盒及其使用方法
RU2734347C1 (ru) * 2019-12-13 2020-10-15 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ прогнозирования оценки эффективности терапии миртазапином для лечения расстройств, сопровождающихся развитием депрессивной симптоматики
RU2717245C1 (ru) * 2019-12-13 2020-03-19 Государственное бюджетное учреждение здравоохранения города Москвы "Московский научно-практический центр наркологии Департамента здравоохранения города Москвы" (ГБУЗ "МНПЦ наркологии ДЗМ") Способ прогнозирования оценки эффективности терапии дапоксетином для лечения расстройств, сопровождающихся развитием депрессивной симптоматики
US20210398631A1 (en) * 2020-06-18 2021-12-23 Genomind, Inc. Systems and methods for displaying a patient specific report
BR112022017770A2 (pt) * 2020-03-06 2022-11-29 Denovo Biopharma Llc Polinucleotídeo isolado; painel de polinucleotídeos isolados; kit que compreende o polinucleotídeo isolado ou painel; microarranjo; reagente; kit que compreende o reagente; kit que compreende o polinucleotídeo isolado ou painel; método de diagnóstico complementar; método para classificar um indivíduo para elegibilidade para um tratamento; método para rastrear um indivíduo ou uma população de indivíduos para um tratamento; método para monitorar um indivíduo durante um tratamento; método para identificar um alvo de fármaco; método para o tratamento de doença ou transtorno do sistema nervoso central (snc) em um indivíduo; uso
JP6893052B1 (ja) * 2020-06-29 2021-06-23 ゲノム・ファーマケア株式会社 投与計画提案システム、方法およびプログラム
CN112174902A (zh) * 2020-09-29 2021-01-05 广州万孚生物技术股份有限公司 一种奥沙西泮半抗原、奥沙西泮抗原及其制备方法和应用
WO2022109165A1 (en) * 2020-11-18 2022-05-27 Indiana University Research And Technology Corporation Methods for objective assessment, risk prediction, matching to existing medications and new methods of using drugs, and monitoring responses to treatments for mood disorders
CN113136424B (zh) * 2021-05-21 2022-04-08 广州合一生物科技有限公司 一种用于抗癫痫药物个体化用药的基因检测试剂盒及其应用
CN113373211A (zh) * 2021-05-26 2021-09-10 郑州大学 一种用于指导焦虑症用药的相关基因检测试剂盒及应用
CN113468867B (zh) * 2021-06-04 2024-06-11 淮阴工学院 一种基于Attention机制的参考文献引用合法性预测方法
CN113755581A (zh) * 2021-09-27 2021-12-07 厦门市仙岳医院(厦门市精神卫生中心) 基质辅助激光解吸飞行时间质谱检测精神类疾病用药相关基因的核酸组合物、试剂盒和方法
CN114941030B (zh) * 2022-04-29 2023-05-05 南京医科大学 一种用于胃癌辅助诊断的snp标志物及其应用
WO2024025536A1 (en) * 2022-07-28 2024-02-01 Indiana University Research And Technology Corporation Precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
CN116515993A (zh) * 2023-06-25 2023-08-01 广州凯普医药科技有限公司 用于抑郁症用药基因检测的引物组和试剂盒
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248832A4 (en) * 2000-01-21 2004-07-07 Variagenics Inc IDENTIFICATION OF GENETIC COMPONENTS IN DRUG REACTION
EP1599576B1 (en) * 2003-02-20 2016-04-27 Mayo Foundation For Medical Education And Research Methods for selecting antidepressant medications
US20100273153A1 (en) * 2006-11-29 2010-10-28 Boris Tabakoff Genetic diagnosis of depression
US7795033B2 (en) * 2007-03-19 2010-09-14 The United States Of America As Represented By The Department Of Health And Human Services Methods to predict the outcome of treatment with antidepressant medication
WO2009036056A1 (en) * 2007-09-10 2009-03-19 Vanda Pharmaceuticals, Inc. Antipsychotic treatment based on snp genotype
US8355927B2 (en) * 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US20140243608A1 (en) * 2011-07-05 2014-08-28 Robert D. Hunt Systems and methods for clinical evaluation of psychiatric disorders

Also Published As

Publication number Publication date
EP2973364A2 (en) 2016-01-20
BR112015022472A2 (pt) 2017-07-18
US20170051350A1 (en) 2017-02-23
US20150292014A1 (en) 2015-10-15
WO2014150817A2 (en) 2014-09-25
WO2014150817A3 (en) 2014-11-13
EP2973364A4 (en) 2016-09-28
US20140274764A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
HK1220279A1 (zh) 預測對精神疾病治療的應答的方法和系統
EP2981623A4 (en) SYSTEMS AND METHOD FOR THE ASSESSMENT OF MICROBIOMES AND TREATMENTS THEREOF
HK1222593A1 (zh) 用於反映體育活動特徵的方法及系統
EP3089466A4 (en) METHOD AND DEVICE FOR INTERACTING ON THE SAME SCREEN
EP2867778A4 (en) POWERFUL INTERMEDIATE STORAGE SYSTEM AND METHOD
HK1210537A1 (zh) 用於實時賬戶訪問的系統和方法
EP2873007A4 (en) SYSTEMS AND METHODS FOR JOINT INTERNET NAVIGATION
EP3031680A4 (en) BRAKE CONTROL DEVICE AND BRAKE CONTROL PROCEDURE
HK1220520A1 (zh) 預測對疼痛治療的應答的方法和系統
SG11201509326TA (en) Ship-type structure and method for designing ship-type structure
HK1215373A1 (zh) 用於治療代謝疾病的方法和裝置
EP2994860A4 (en) SYSTEM AND METHOD FOR PROVIDING SECURE REMOTE ACCESS TO COMPUTER-BASED WORK
GB2531231B (en) Improved aircraft gate parking and servicing method
HK1205305A1 (zh) 用於允許任何語言作為密碼的方法和系統
IL240812A0 (en) Unit and method for corona treatment
IL227627A0 (en) Method and device for determining geographic location
EP2967406A4 (en) METHOD AND SYSTEM FOR CALCULATING A QEEG
GB201305411D0 (en) System and method
EP2940931A4 (en) METHOD AND DEVICE FOR UTILIZING AN INACTIVE CONNECTION
EP2972969A4 (en) COMPUTER SYSTEM HAVING A DEVICE INTERACTION MECHANISM AND METHOD OF OPERATION
EP2940933A4 (en) METHOD FOR NODE DEVICE FOR ENTERING OR LEAVING AN ENERGY SAVING MODE AND KNOT DEVICE
GB2518676B (en) Telematics system and associated method
ZA201508813B (en) System and method for facilitating transactions
GB2512996B (en) System and method of arbitrating access to interconnect
GB201320220D0 (en) System and method for Authorising access to facilities